A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition

Biochemical and Biophysical Research Communications

Volumn 435, Issue 3, 2013, Pages 339-344

  Jung, Young Suk ^a   Kato, Ikuko ^a   Kim, Hyeong Reh Choi ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell invasion; EMT activating transcription factor; Epithelial mesenchymal transition; Head and neck squamous cell carcinomas; Human papillomavirus

Indexed keywords

PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM; HEAD AND NECK CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MESENCHYME; METASTASIS; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; DOGS; EPITHELIAL-MESENCHYMAL TRANSITION; HEAD AND NECK NEOPLASMS; HOST-PATHOGEN INTERACTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS - 16; HUMAN PAPILLOMAVIRUS TYPE 16; NICOTIANA TABACUM;

EID: 84878988773     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.060     Document Type: Article

References (27)

1. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
2. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.
3. Gillison M.L., Chaturvedi A.K., Lowy D.R. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008, 113:3036-3046.
4. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11:781-789.
5. Cooper J.S., Pajak T.F., Forastiere A.A., Jacobs J., Campbell B.H., Saxman S.B., Kish J.A., Kim H.E., Cmelak A.J., Rotman M., Machtay M., Ensley J.F., Chao K.S., Schultz C.J., Lee N., Fu K.K. I. Radiation Therapy Oncology Group, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 2004, 350:1937-1944.
6. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 2008, 26:612-619.
7. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., Zahurak M.L., Daniel R.W., Viglione M., Symer D.E., Shah K.V., Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000, 92:709-720.
8. D'Souza G., Kreimer A.R., Viscidi R., Pawlita M., Fakhry C., Koch W.M., Westra W.H., Gillison M.L. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 2007, 356:1944-1956.
9. Andl T., Kahn T., Pfuhl A., Nicola T., Erber R., Conradt C., Klein W., Helbig M., Dietz A., Weidauer H., Bosch F.X. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res. 1998, 58:5-13.
10. Fakhry C., Gillison M.L. Clinical implications of human papillomavirus in head and neck cancers. J. Clin. Oncol. 2006, 24:2606-2611.
11. Ghittoni R., Accardi R., Hasan U., Gheit T., Sylla B., Tommasino M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010, 40:1-13.
12. Pim D., Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS 2010, 118:471-493.
13. Bhave S.L., Teknos T.N., Pan Q. Molecular parameters of head and neck cancer metastasis. Crit. Rev. Eukaryot. Gene Expr. 2011, 21:143-153.
14. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
15. Chung C.H., Parker J.S., Ely K., Carter J., Yi Y., Murphy B.A., Ang K.K., El-Naggar A.K., Zanation A.M., Cmelak A.J., Levy S., Slebos R.J., Yarbrough W.G. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res. 2006, 66:8210-8218.
16. Yang T.L., Wu C.T., Ko J.Y., Wang C.P., Lou P.J., Chang Y.L. Significance of tumor satellite variables in reflecting the epithelial-mesenchymal transition of tongue cancer. Oral Oncol. 2011, 47:720-724.
17. Pai S.I., Westra W.H. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu. Rev. Pathol. 2009, 4:49-70.
18. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
19. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
20. Sanchez-Tillo E., Liu Y., de Barrios O., Siles L., Fanlo L., Cuatrecasas M., Darling D.S., Dean D.C., Castells A., Postigo A. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol. Life Sci. 2012, 69:3429-3456.
21. Taube J.H., Herschkowitz J.I., Komurov K., Zhou A.Y., Gupta S., Yang J., Hartwell K., Onder T.T., Gupta P.B., Evans K.W., Hollier B.G., Ram P.T., Lander E.S., Rosen J.M., Weinberg R.A., Mani S.A. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc. Natl. Acad. Sci. USA 2010, 107:15449-15454.
22. Reinhold W.C., Reimers M.A., Lorenzi P., Ho J., Shankavaram U.T., Ziegler M.S., Bussey K.J., Nishizuka S., Ikediobi O., Pommier Y.G., Weinstein J.N. Multifactorial regulation of E-cadherin expression: an integrative study. Mol. Cancer Ther. 2010, 9:1-16.
23. Matthews K., Leong C.M., Baxter L., Inglis E., Yun K., Backstrom B.T., Doorbar J., Hibma M. Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin. J. Virol. 2003, 77:8378-8385.
24. Vessey C.J., Wilding J., Folarin N., Hirano S., Takeichi M., Soutter P., Stamp G.W., Pignatelli M. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. J. Pathol. 1995, 176:151-159.
25. Caberg J.H., Hubert P.M., Begon D.Y., Herfs M.F., Roncarati P.J., Boniver J.J., Delvenne P.O. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis 2008, 29:1441-1447.
26. Laurson J., Khan S., Chung R., Cross K., Raj K. Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis 2010, 31:918-926.
27. D'Costa Z.J., Jolly C., Androphy E.J., Mercer A., Matthews C.M., Hibma M.H. Transcriptional repression of E-cadherin by human papillomavirus type 16 E6. PLoS One 2012, 7:e48954.